Related Experiment Videos
Metoprolol treatment after acute myocardial infarction. Effects on ventricular arrhythmias and exercise tests during
Insights
Metoprolol treatment after acute myocardial infarction initially reduced malignant ventricular arrhythmias. However, this effect was temporary, with no long-term improvement in cardiac function or exercise capacity observed.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction (MI) poses significant risks, including ventricular arrhythmias.
- Early post-MI management aims to prevent adverse cardiac events and improve outcomes.
Purpose of the Study:
- To investigate the efficacy of metoprolol in managing ventricular arrhythmias and improving exercise capacity in patients post-MI.
- To assess the impact of metoprolol on infarct size, arrhythmias, and cardiac function during the first six months after acute MI.
Main Methods:
- A double-blind study involving 106 patients randomized to placebo or metoprolol (100 mg b.i.d.).
- Patients stratified by ventricular arrhythmias, infarct size, and age.
- Six-hour ECG recordings and exercise tests performed at baseline and follow-up intervals.
Main Results:
- Metoprolol significantly decreased malignant ventricular ectopic beats within three days (p < 0.05), an effect sustained for one month but not at six months.
- No significant differences observed in working capacity or ischemic ST depressions during exercise between groups.
- Increased fatigue led to exercise discontinuation in more patients on metoprolol at six months (p < 0.05).
Conclusions:
- Metoprolol demonstrates a transient benefit in reducing ventricular arrhythmias early post-MI.
- Long-term metoprolol treatment did not improve exercise capacity or reduce ischemic ST depressions.
- Further research is needed to understand the long-term implications of metoprolol on post-MI cardiac function and patient-reported outcomes.
Abstract:
One hundred and six patients on double-blind treatment with placebo or metoprolol, 100 mg b.i.d., during the first 6 months after an acute myocardial infarction were investigated. The patients were stratified and randomized to treatment according to type of ventricular arrhythmias on a six-hour ECG registration, size of infarct estimated by enzyme maximum and age. During the follow-up period, a further three six-hour ECG recordings and three exercise tests were performed. In the metoprolol group the incidence of malignant ventricular ectopic beats decreased significantly (p less than 0.05) after three days' treatment. This decrease lasted for one month but was not observed at the six-month registration. No difference in working capacity was seen between the two groups, nor were there any differences in ischemic ST depressions on ECG during exercise. The proportion of patients terminating exercise because of angina pectoris was similar, but significantly more patients in the metoprolol group (p less than 0.05) discontinued exercise at six months because of fatigue. Large heart volumes were observed somewhat more often in the metoprolol group but there was no extended need of treatment for cardiac failure.